<code id='1E8D794C19'></code><style id='1E8D794C19'></style>
    • <acronym id='1E8D794C19'></acronym>
      <center id='1E8D794C19'><center id='1E8D794C19'><tfoot id='1E8D794C19'></tfoot></center><abbr id='1E8D794C19'><dir id='1E8D794C19'><tfoot id='1E8D794C19'></tfoot><noframes id='1E8D794C19'>

    • <optgroup id='1E8D794C19'><strike id='1E8D794C19'><sup id='1E8D794C19'></sup></strike><code id='1E8D794C19'></code></optgroup>
        1. <b id='1E8D794C19'><label id='1E8D794C19'><select id='1E8D794C19'><dt id='1E8D794C19'><span id='1E8D794C19'></span></dt></select></label></b><u id='1E8D794C19'></u>
          <i id='1E8D794C19'><strike id='1E8D794C19'><tt id='1E8D794C19'><pre id='1E8D794C19'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:491
          Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

          After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

          The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

          advertisement

          The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          PrEP can help anyone prevent HIV. Why do so few people take it?
          PrEP can help anyone prevent HIV. Why do so few people take it?

          Truvada,thepre-exposureprophylaxispillmanufacturedbyGilead.JustinSullivan/GettyImagesAbout60%ofolder

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Life sciences deals on track to hit lowest point since 2017

          AdobeIt’snosecretthatbiotechindustryfundinghasfallenfromitsCovidhighs.Butwithjustafewmonthsleftinthe